Filed with the SEC on · Summarized by InvestorsBot
Jennifer L. Davis resigned from AbbVie’s Board of Directors effective November 2, 2026, following her appointment as chief executive officer of Align Technology, Inc. AbbVie said the resignation was not due to any dispute or disagreement with the company’s operations, policies or practices.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeAbbVie raises 2026 guidance as third-quarter revenue rises 10.3%
8-K · October 30, 2026
AbbVie Adds John Carethers as Independent Director
8-K · October 15, 2026
AbbVie includes $216 million expense in Q3 and lowers 2026 EPS guidance
8-K · October 5, 2026
AbbVie Completes $10 Billion Debt Offering to Fund Apogee Acquisition
8-K · August 18, 2026
AbbVie EVP Nicholas Donoghoe sells $8.2M in stock
Form 4 · Insider Trade · August 18, 2026
AbbVie launches $10 billion bond offering to fund Apogee acquisition
8-K · August 5, 2026